Cumberland Pharmaceuticals
James L. Herman has been in the pharmaceutical industry for over 25 years. James began their career at Schwarz Pharma in 1990 as a Manager. In 1998, they left Schwarz to join Solvay Pharmaceuticals as Director. James remained with Solvay until 2003 when they joined Cumberland Pharmaceuticals as SVP, National Accounts & Chief Compliance Officer.
James L. Herman has a MBA in Finance from Cardinal Stritch University and a B.S. in Marketing from Indiana University Bloomington.
James L. Herman reports to A.J. Kazimi, Chairman & CEO. They are on a team with Todd Anthony - Senior Director, Organizational Development, Adam S. Mostafa - Managing Director, Consultant, and Barry Lee - Director, Hospital Products.
This person is not in any offices
Cumberland Pharmaceuticals
2 followers
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs. With a focus on underserved niche markets, including hospital acute care and gastroenterology, they deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships. They own the worldwide rights to all their brands. While Cumberland’s commercial capabilities are focused on the U.S. market, their business development team is actively pursuing opportunities to make their brands available to patients in markets around the globe. Their primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. They also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients.